https://www.thebodypro.com/tag/id-week

IDWeek

The Latest

Promo Image

What's Hot in HIV Treatment

Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.

HIV Attachment Inhibitor BMS-663068 Compares Well to Boosted Atazanavir at 24 Weeks Img

HIV Attachment Inhibitor BMS-663068 Compares Well to Boosted Atazanavir at 24 Weeks

In its bid to become the first approved member of a new class of HIV medications, the attachment inhibitor BMS-663068, also known as "068" or fostemsavir, showed similar efficacy to ritonavir (Norvir)-boosted atazanavir (Reyataz) in Phase 2b study re...

Anal Cancer Screening Warranted for Heterosexuals With HIV, Not Just MSM Img

Anal Cancer Screening Warranted for Heterosexuals With HIV, Not Just MSM

Heterosexual HIV-infected men and women have a high prevalence of markers associated with anal cancer, such as infection with high-risk human papillomavirus (hr-HPV) and cytological abnormalities, according to study results presented at IDWeek 2013. ...

Should HIV-Serodiscordant Couples Always Take Preventive Measures? Experts Debate Img

Should HIV-Serodiscordant Couples Always Take Preventive Measures? Experts Debate

You're in a long-term, committed, monogamous relationship with a loving partner. You don't have HIV, but your partner does -- and is on stable, successful HIV treatment. Is unprotected sex "safe enough"?

Excessive Drinking May Be a Problem Among Young, White People With HIV Img

Excessive Drinking May Be a Problem Among Young, White People With HIV

HIV meds appear more likely to stop working among HIV-positive people who frequently drink alcohol -- but frequent drinking doesn't seem to have a bad effect on CD4 counts.

Early Treatment and Weight Management May Prevent Common Comorbidities in Young People Living With HIV Img

Early Treatment and Weight Management May Prevent Common Comorbidities in Young People Living With HIV

Newly diagnosed people often have two or more additional health problems, such as depression, high cholesterol or high blood pressure. But research shows all of these issues can be tackled alongside HIV.

Colorectal Cancer Screening Rates Extremely Low Among People With HIV Img

Colorectal Cancer Screening Rates Extremely Low Among People With HIV

HIV-positive people rarely receive proper screening for colorectal cancer in the U.S., making it hard for researchers to gauge just how common it is.

Racial Differences Seen in Comparison of Stribild and Atripla as First-Line Therapy Img

Racial Differences Seen in Comparison of Stribild and Atripla as First-Line Therapy

A new study finds that black people are less likely to keep their viral load down on Atripla -- and that more trouble with side effects may be the reason.

Lipids Respond Well to Switch From Boosted PI to Rilpivirine/Tenofovir/Emtricitabine (Complera), Study Finds Img

Lipids Respond Well to Switch From Boosted PI to Rilpivirine/Tenofovir/Emtricitabine (Complera), Study Finds

Many people who had high lipid levels while taking common HIV treatment regimens that included a protease inhibitor, such as Prezista or Reyataz, saw remarkable improvements after the switch.

Suicide Risk Doubles Among HIV-Infected People Taking Efavirenz, Study Finds Img

Suicide Risk Doubles Among HIV-Infected People Taking Efavirenz, Study Finds

Mental health really matters in HIV. We got a hugely important reminder of that this month in the form of new research regarding suicide and Sustiva (one of the drugs in Atripla).